This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More
Discovery Laboratories Inc
DSCO : NASDAQ : Health Care
$1.54 0.01 | 0.65%
Today's Range: 1.53 - 1.57
Avg. Daily Volume: 246,500
11/26/14 - 1:36 PM ET

PEER GROUP: Biotechnology

Ticker Company Name Recent
Net Sales
Net Income
DSCO DISCOVERY LABORATORIES INC 1.53 130.57 n/m 1.72 238.03
NAVB NAVIDEA BIOPHARMACEUTICALS 1.21 182.40 n/m 4.61 664.67
PSTI PLURISTEM THERAPEUTICS INC 2.60 182.20 n/m 0.38 -44.19
NBS NEOSTEM INC 4.45 159.03 n/m 16.74 25.47
CBMG CELLULAR BIOMEDICINE GROUP 15.50 154.16 n/m 4.14 413700.00
CYTK CYTOKINETICS INC 4.14 151.56 n/m 49.53 483.88
SNSS SUNESIS PHARMACEUTICALS INC 2.07 128.23 n/m 6.83 -14.20
KMDA KAMADA LTD 3.28 118.01 n/m 70.57 52.77
ADMA ADMA BIOLOGICS INC 12.08 112.25 n/m 4.59 199.02
ICEL CELLULAR DYNAMICS INTL INC 7.01 110.86 n/m 14.30 168.07
SRNE SORRENTO THERAPEUTICS INC 3.81 110.23 n/m 1.94 263.03
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

DSCO Ind Avg S&P 500
n/m 64.35 19.91

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades

Top Rated Stocks Top Rated Funds Top Rated ETFs